Metrics to compare | 000520 | Sector Sector - Average of metrics from a broad group of related Healthcare sector companies | Relationship Relationship000520PeersSector | |
|---|---|---|---|---|
P/E Ratio | −4.2x | 1.3x | −0.2x | |
PEG Ratio | 0.05 | 0.02 | 0.00 | |
Price/Book | 1.2x | 0.6x | 2.6x | |
Price / LTM Sales | 0.8x | 0.5x | 2.8x | |
Upside (Analyst Target) | 36.2% | 48.1% | 62.1% | |
Fair Value Upside | Unlock | 27.4% | 9.5% | Unlock |
Samil Pharmaceutical Co.,Ltd engages in the manufacture and sale of pharmaceuticals in South Korea. It offers general medicines, including Tiersil Once, EYE2O mini eye drops, and Optagent ophthalmic drops; medical devices; secret spotpatch quasi-drugs, and roll away products. The company also provides specialty medicines, such as Hycell solutions; Curelen, Ocufridine, Ocumetholone, Ocucyclo, Ocuhomapine, Ocucarpine, Allerfen, Optanac, Forus, Eymox, Cifex, and Ocuracin ophthalmic drops; and Herpecid, Forus, and Ocurasin ophthalmic ointments. Samil Pharmaceutical Co.,Ltd was founded in 1947 and is headquartered in Seoul, South Korea.